"A multispecialty community and teaching hospital providing quality health care services to the residents of Greater New Britain, Connecticut."

During the past decade, New Britain General Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Britain General Hospital" #1 sponsor was "Gynecologic Oncology Group" with 2 trials, followed by "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Applied Spine Technologies" with 1 trials sponsored, "Aronex Pharmaceuticals" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Britain General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "New Britain General Hospital" are "Pancreatic Cancer" (3 trials), "Breast Cancer" (2 trials), "Anxiety Disorder" (1 trials), "Chronic Myeloproliferative Disorders" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "New Britain General Hospital" in a lesser frequency.

Most popular intervention types in "New Britain General Hospital" are "Drug" (12 trials), "Biological" (1 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "oxaliplatin" (2 trials), "Desvenlafaxine Succinate" (1 trials), "Gemcitabine" (1 trials) and "Raloxifene" (1 trials). Other intervention names were less common.

The vast majority of trials in "New Britain General Hospital" are 9 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "New Britain General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in New Britain General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Britain General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".